Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting AMPK by Statins: A Potential Therapeutic Approach
Sajad Dehnavi, Amirhossein Kiani, Mahvash Sadeghi, et al.
Drugs (2021) Vol. 81, Iss. 8, pp. 923-933
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

The Immune Regulatory Role of Adenosine in the Tumor Microenvironment
Jianlei Xing, Jinhua Zhang, Jinyan Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14928-14928
Open Access | Times Cited: 31
New insights into the therapeutic potentials of statins in cancer
Chengyu Liu, Hong Chen, Bicheng Hu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 30
Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target
Dan Li, Shengjie Yang, Yanwei Xing, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 44
The role of microglia immunometabolism in neurodegeneration: Focus on molecular determinants and metabolic intermediates of metabolic reprogramming
Qixue Wang, Mengna Lu, Xinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113412-113412
Open Access | Times Cited: 32
Effect of Statins on Prevalence and Mortality of Influenza Virus Infection: A Systematic Review and Meta-Analysis
Amir Vahedian‐Azimi, Massimo R. Mannarino, Sajad Shojaie, et al.
Archives of Medical Science (2022) Vol. 18, Iss. 6, pp. 1-44
Open Access | Times Cited: 26
Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
Victoria Campos‐Peña, Pavel Pichardo-Rojas, Talía Sánchez-Barbosa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12092-12092
Open Access | Times Cited: 26
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Francisco Alejandro Lagunas‐Rangel, E. Liepinsh, Robert Fredriksson, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 20, pp. 3799-3818
Open Access | Times Cited: 5
Anti-flavivirus Properties of Lipid-Lowering Drugs
Carlos Noe Farfan‐Morales, Carlos Daniel Cordero‐Rivera, José Manuel Reyes-Ruíz, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 30
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis
Yoshimi Endo Greer, Lídia Hernandez, Emily M.J. Fennell, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 10, pp. 1144-1161
Open Access | Times Cited: 21
Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions
Amir Tajbakhsh, Seyed Mohammad Gheibihayat, Hassan Askari, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108282-108282
Closed Access | Times Cited: 21
Therapeutic effects of statins on osteoarthritis: A review
Shirin Saberianpour, Samaneh Abolbashari, Mohamad Hadi Saeed Modaghegh, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 8, pp. 1285-1297
Open Access | Times Cited: 20
Spectroscopic studies on the antioxidant and anti-tyrosinase activities of anthraquinone derivatives
Velmurugan Loganathan, Akbar Idhayadhulla, Mohammad Z. Ahmed, et al.
Journal of King Saud University - Science (2023) Vol. 35, Iss. 10, pp. 102971-102971
Open Access | Times Cited: 12
Przewaquinone A inhibits Angiotensin II-induced endothelial diastolic dysfunction activation of AMPK
Si Chen, Jun-di Xie, Meng-ting Xie, et al.
Phytomedicine (2024) Vol. 133, pp. 155885-155885
Closed Access | Times Cited: 4
AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension
Karen Flores, Patricia Siqués, Julio Brito, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6205-6205
Open Access | Times Cited: 19
Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases
Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Seyed Saeed Tamehri Zadeh, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 57-75
Open Access | Times Cited: 18
Ebastine-mediated destabilization of E3 ligase MKRN1 protects against metabolic dysfunction-associated steatohepatitis
Seungyeon Kim, Hyun-Ji Han, Hyunjin Rho, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Could statins represent a new frontier for improving outcomes with neoadjuvant chemotherapy in hormone receptor-positive, HER2-negative breast cancer
Mustafa ERSOY
Research Square (Research Square) (2025)
Closed Access
Statin Therapy for NAFLD: Molecular underpinnings of Myopathic Consequences and Treatment Strategies
Pratiksha V. Nanepag, Shubhada Mangrulkar, Aarti Shriwas, et al.
Aspects of Molecular Medicine (2025), pp. 100091-100091
Open Access
Hempseed (Cannabis sativa) Peptide H3 (IGFLIIWV) Exerts Cholesterol-Lowering Effects in Human Hepatic Cell Line
Jianqiang Li, Carlotta Bollati, Martina Bartolomei, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1804-1804
Open Access | Times Cited: 16
Statins and angiogenesis in non-cardiovascular diseases
Fatemeh Zahedipour, Alexandra E. Butler, Manfredi Rizzo, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103320-103320
Closed Access | Times Cited: 16
Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease
Fatemeh Zahedipour, Alexandra E. Butler, Ali H. Eid, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103325-103325
Open Access | Times Cited: 15
Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives
Alireza Mafi, Hamidreza Rismanchi, Yasaman Gholinezhad, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study
Khlood Mohammad Aldossary, Lashin Saad Ali, Mahmoud S. Abdallah, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases
Danial Khayatan, Seyed Mehrad Razavi, Zahra Najafi Arab, et al.
Life (2022) Vol. 12, Iss. 5, pp. 760-760
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top